Luigi Melcarne

TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysis

Belén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, Stephanie Coward et autres

Few studies have assessed the distribution and temporal trends of healthcare expenditures related to inflammatory bowel disease (IBD). The aims of the study were to analyze the expenditure trends for IBD patients in Catalonia from 2011 to 2024, to identify key cost …

TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysis

Belén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, Stephanie Coward et autres

Few studies have assessed the distribution and temporal trends of healthcare expenditures related to inflammatory bowel disease (IBD). The aims of the study were to analyze the expenditure trends for IBD patients in Catalonia from 2011 to 2024, to identify key cost …

TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysis

Belén Garcia-Sagué, E Brunet-Mas, Emili Vela, S Coward et autres

INTRODUCTION: Few studies have assessed the distribution and temporal trends of healthcare expenditures related to inflammatory bowel disease (IBD). The aims of the study were to analyze the expenditure trends for IBD patients in Catalonia from 2011 to 2024, to identify key …

es, gb, ca (code pays fourni par la source)

The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial

Mariam Aguas, Javier Del Hoyo, Raquel Vicente, Manuel Barreiro-de Acosta et autres

BACKGROUND & AIMS: Evidence on the economic impact of telemonitoring in inflammatory bowel disease is limited. We evaluated the cost-effectiveness and cost-utility of nationwide inflammatory bowel disease telemonitoring compared with standard care. METHODS: A multicenter, randomized, noninferiority trial was performed in 24 …

es (code pays fourni par la source)

34 - EVOLUCIÓN Y PREDICCIÓN DEL IMPACTO ECONÓMICO DE LA ENFERMEDAD INFLAMATORIA INTESTINAL EN CATALUÑA: UN ESTUDIO BASADO EN LA POBLACIÓN

Belen Garcia Sague, Eduard Brunet, Emili Vela, Caridad Pontes et autres

135 - BEVACIZUMAB COMO TERAPIA DE RESCATE PARA ANGIODISPLASIAS GASTROINTESTINALES Y GAVE REFRACTARIOS: REPORTE DE LA EXPERIENCIA DE DOS CENTROS

Sebastián Alejandro Romero Velasteguí, Belen Garcia Sague, Eduard Brunet Mas, Pilar García Iglesias et autres

Real-world management of SeHCAT-confirmed bile acid diarrhoea: response to colestyramine and predictors of treatment success

Eduard Brunet-Mas, Andrea Peña-Rosado, Belen Garcia-Sagué, Luis Enrique Frisancho et autres

Abstract Background Bile acid diarrhoea (BAD) is an increasingly recognized cause of chronic diarrhoea. The 75-selenium homocholic acid taurine (SeHCAT) test remains the gold standard for diagnosis. The primary pharmacological treatment involves bile acid–binding agents, most commonly colestyramine. This study aimed to …

es (code pays fourni par la source)

Development and validation of the inflammatory bowel disease objective disability index (IBDODI)

Luigi Melcarne, Eduard Brunet Mas, Albert Villoria Ferrer, Mercedes Vergara et autres

INTRODUCTION: Current measuring tools for disability related to inflammatory bowel disease (IBD) rely mostly on patient-reported disability perception. It may, therefore, largely depend on patients' subjectivity, thus hindering objective evaluation. In the present study, we aimed to identify clinical plausibly objectifiable variables …

es (code pays fourni par la source)

Prevalence, incidence and mortality of pediatric inflammatory bowel disease in Catalonia (EPIBDCat)

Eduard Brunet, Inés Loverdos, Emili Vela, Clara Comalrena de Sobregrau et autres

OBJECTIVES: The epidemiologic status of pediatric inflammatory bowel disease (PIBD) has not been widely studied in Western Europe. The prevalence and incidence trends of the disease are largely unknown. The aim of this study was to determine the prevalence, incidence and mortality …

es (code pays fourni par la source)

Time trends of pediatric inflammatory bowel disease in Catalonia from 2011 to 2023. Population-based cohort study

Eduard Brunet-Mas, Diana Garcia, Emili Vela, Clara Comalrena et autres

INTRODUCTION: Data on temporal trends in treatment use in pediatric inflammatory bowel disease (PIBD) are limited. This study aimed to evaluate treatment trends in PIBD in Catalonia and to explore their association with outcomes, including surgery and hospitalization. MATERIAL AND METHODS: We …

es (code pays fourni par la source)

Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023

Eduard Brunet, Belén García-Sagué, Emili Vela, Caridad Pontes et autres

Background: The prevalence of inflammatory bowel disease (IBD) is increasing worldwide, while the incidence is tending to stabilize. Moreover, the use of biological treatments is increasing; some studies suggest that surgeries and hospitalizations are decreasing instead. Methods: A population-based, retrospective cohort study …

es, gb (code pays fourni par la source)

Prevalence, Incidence, Mortality and Trends in Treatment of Inflammatory Bowel Disease in Catalonia Between 2017 and 2023. An Epidemiological Update

Belén García-Sagué, Emili Vela, Caridad Pontes, Luigi Melcarne et autres

Background: Prevalence of inflammatory bowel disease (IBD) is increasing worldwide, while incidence is tending to stabilize. Moreover, the use of biological treatments is increasing, some studies suggest that surgeries and hospitalizations are decreasing instead. Methods: A population-based, retrospective cohort study was conducted …

gb (code pays fourni par la source)